Vote Scores

Home / Companies / Adaptive Biotechnologies Corporation / 5 Jun 2026

Meeting · year to 30 June 2026440 filers reporting

Adaptive Biotechnologies Corporation: meeting of 5 Jun 2026

Votes reported on Form N-PX, item by item

440 Form N-PX filers reported votes at the Adaptive Biotechnologies Corporation meeting of 5 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 74.1% of reported votes for; 84 filers withheld from or voted against at least one nominee.

584 vote records from 163 filers. 5 of the 163 filers that marked the item either way voted against management.

57.7% for0.0% against42.3% other3.1% against management163 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

636 vote records from 438 filers. 17 of the 420 filers that marked the item either way voted against management. 18 filers reported this item without a management mark.

91.1% for3.9% against5.0% other4.0% against management438 filers97.7% for2.2% against0.1% other2.2% against management159,408,391 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

292 vote records from 163 filers. 1 of the 163 filers that marked the item either way voted against management.

99.4% for0.0% against0.6% other0.6% against management163 filers100.0% for0.0% against0.0% other0.0% against management50,965,957 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalAbstain or withhold *ForFor
State Street and SPDRForForFor
American CenturySplit or no voteAgainst *For
Franklin TempletonSplit or no voteForFor
InvescoForForFor
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAASplit or no voteForFor
ProShares and ProFundsSplit or no voteForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertSplit or no voteForFor
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesSplit or no voteForFor
SEIForForFor
T. Rowe PriceForForFor
ThriventSplit or no voteForFor
Lincoln FinancialForForFor
VoyaSplit or no voteForFor
First TrustSplit or no voteForFor
Russell InvestmentsForForFor
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexSplit or no voteForFor
Columbia ThreadneedleForForFor
BNY MellonNo reportForNo report
PrincipalSplit or no voteForFor
Pacific Life fundsForForFor
Global XForForFor
MFSSplit or no voteForFor
TransamericaForForFor
AllianceBernsteinNo reportForNo report
Hartford FundsForForFor
DWSSplit or no voteForFor
AllspringSplit or no voteForFor
MassMutualForForFor
Harbor FundsForForFor
Macquarie and Delaware FundsSplit or no voteForFor
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report
Lord AbbettForForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Adaptive Biotechnologies Corporation meeting?

440 Form N-PX filers reported votes at the meeting of 5 Jun 2026. On say-on-pay, 17 of 420 voted against management (4.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Adaptive Biotechnologies Corporation on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Adaptive Biotechnologies Corporation

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Adaptive Biotechnologies Corporation with a meeting date within three days of 5 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.